Welcome to our dedicated page for Innovation Beverage Group SEC filings (Ticker: IBG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
When you open an Innovation Beverage Group (IBG) filing, you are often searching for niche details—how Australian Bitters sales compare to cocktail mixer growth, whether new distributor contracts boost U.S. reach, or if supply-chain risks around rare botanicals are material. Our page answers those real questions by making every Innovation Beverage Group SEC filing explained simply and available the moment it hits EDGAR.
Use Stock Titan’s AI to glide from headline to footnote. One click converts a 10-K into a concise brief that highlights segment revenue, capital spending on bottling lines, and critical risk factors. Need the latest Innovation Beverage Group quarterly earnings report 10-Q filing? It’s paired with AI commentary on margin trends. Curious about Innovation Beverage Group insider trading Form 4 transactions? Real-time alerts track every Innovation Beverage Group Form 4 insider transactions real-time so you can see exactly when executives buy or sell shares. We also map each proxy statement executive compensation table, flag 8-K material events, and link distributor agreements cited in exhibits.
Practical use cases abound: monitor Innovation Beverage Group executive stock transactions Form 4 before product launches, compare ingredient cost swings quarter over quarter, or study how intellectual-property notes in the Innovation Beverage Group annual report 10-K simplified protect the Australian Bitters recipe. Whether you’re a portfolio manager seeking Innovation Beverage Group earnings report filing analysis or a research analyst focused on understanding Innovation Beverage Group SEC documents with AI, our complete, continuously updated library keeps you ahead.
Innovation Beverage Group Limited (IBG) has filed a Form 144 notice signaling its intent to sell 1,243,828 common shares—the same quantity reported as outstanding—through broker Dominari Securities (725 Fifth Avenue, New York). The filing assigns an aggregate market value of $1.20 million, indicating a reference price near $0.96 per share. The shares were originally acquired on 29 April 2022 as a gift from Amit Beri (who obtained them on 1 May 2018). The proposed sale is expected to occur on or about 7 July 2025 on the Nasdaq exchange. The filer reports no other dispositions in the past three months and certifies that no undisclosed material adverse information is known at the time of filing.